Impact News +++ SMCP - Update on the forced proceeding of the related shares July 2025 (GlobeNewswire EN) +++ SMCP Aktie +3,53%

INDIVIOR Aktie

>INDIVIOR Aktienkurs

13.1 EUR +0.0% (Tradegate)

Ask: 13.2 EUR / 390 Stück

Bid: 13 EUR / 400 Stück

Tagesumsatz: 76 Stück

Realtime Kurs von 8 bis 22 Uhr!

INDIVIOR Aktie über LYNX handeln

Intraday

1 Jahr

>INDIVIOR Performance

1 Woche: +12,9%

1 Monat: +17,0%

3 Monate: +53,2%

6 Monate: +7,4%

1 Jahr: -6,4%

laufendes Jahr: +10,1%

>INDIVIOR Aktie

Name:

INDIVIOR PLC DL 0,50

Land:

Großbritannien

Sektor:

Gesundheit

ISIN/ Wkn:

GB00BN4HT335 / A3DWFC

Symbol/ Ticker:

2IVB (Frankfurt)

Kürzel:

FRA:2IVB, ETR:2IVB, 2IVB:GR

Index:

Webseite:

https://www.indivior.com/

Marktkapitalisierung:

1500 Mio. EUR

Umsatz:

1012.98 Mio. EUR

EBITDA:

267.53 Mio. EUR

Gewinn je Aktie:

-0.035 EUR

Schulden:

320.34 Mio. EUR

Liquide Mittel:

322.94 Mio. EUR

Umsatz-/ Gewinnwachstum:

-6.3% / -23%

KGV/ KGV lG:

274.52 / -

KUV/ KBV/ PEG:

1.48 / 147.14 / -

Gewinnm./ Eigenkapitalr.:

-5.3% / -

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Div. Historie:

16.06.16 - 0.4235€
17.09.15 - 0.1415€

Insiderhandel:

Suchwörter:

INDIVIOR

Letzte Datenerhebung:

04.07.25

>INDIVIOR Eigentümer

Aktien: 124.77 Mio. St.

f.h. Aktien: 89.72 Mio. St.

Insider Eigner: 4.02%

Instit. Eigner: 88.98%

Leerverk. Aktien: 6.4%

>INDIVIOR Peer Group

ARECOR

CHILL BRANDS

HIKMA

LIVANOVA

NOVOCURE

POOLBEG

RENALYTIX

ROYALTY PHARMA

SMITH & NEPHEW

SOLVONIS

>INDIVIOR Chart & Kurs - Tradegate

>INDIVIOR News

01.07.25 - 14:30	Indivior (INDV) Moves 5.7% Higher: Will This Strength Last? (Zacks)
	Indivior (INDV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....

30.06.25 - 13:27	Indivior to join Russell 2000 Index (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.06.25 - 13:01	Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes (PR Newswire)
	RICHMOND, Va., June 30, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq / LSE: INDV) will be added as a member of the U.S. small-cap Russell 2000® Index, effective after the U.S. market opens today as part of the 2025 Russell indexes reconstitution. The annual reconstitution of the Russell U.S.......

24.06.25 - 22:15	Indivior Appoints Tony Kingsley to the Board of Directors (PR Newswire)
	RICHMOND, Va., June 24, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq / LSE: INDV) today announced the appointment of Tony Kingsley to the Board of Directors as an Independent Non-Executive Director, effective July 1, 2025. Mr. Kingsley was appointed pursuant to Indivior's relationship......

02.06.25 - 15:00

Drugmaker Invidior to abandon London listing amid exodus of companies (The Guardian)

Firm behind opioid addiction treatment drugs quits London Stock Exchange after moving primary to US last yearBusiness live – latest updatesThe drugmaker Indivior has become the latest company to abandon its listing in London, heaping further pressure on the London Stock Exchange (LSE) to reinvigorate itself.The Virginia-based company, which makes the opioid addiction treatments Sublocade and Suboxone, switched its main stock listing to the US last year, but now plans to cancel the secondary listing it had retained in London. Continue reading......

02.06.25 - 12:45	Weiteres Unternehmen verabschiedet sich von Londoner Börse - Indivior geht (Reuters)
	Um den gesamten Artikel unter onvista.de zu lesen, klicken Sie bitte auf die Überschrift...

02.06.25 - 11:36	Indivior to cancel secondary listing in London (ShareCast)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

02.06.25 - 10:54	Indivior drops London listing to focus on U.S. market (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.06.25 - 10:24	Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

02.06.25 - 09:42	Indivior Plans to Cancel London Listing After Moving Primary to US (Bloomberg)
	Indivior Plc said it plans to cancel its secondary listing in London nearly a year after the drugmaker shifted its primary trading to the US, marking the latest departure from the UK's capital markets....

02.06.25 - 08:03	Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained (PR Newswire)
	SLOUGH, England and RICHMOND, Va., June 2, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its intention to cancel: (i) the secondary listing of the Company's Ordinary Shares ("Ordinary Shares") on the Equity Shares (Transition) category of the Official List (the......

27.05.25 - 14:36	Indivior Announces Patrick Barry as Chief Commercial Officer (PR Newswire)
	Seasoned commercial executive with more than 30 years of pharmaceutical experience RICHMOND, Va., May 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the appointment of Patrick Barry as Chief Commercial Officer, effective June 2. In this role, Barry will lead the......

13.05.25 - 16:03	Indivior to Participate in Upcoming Investor Events (PR Newswire)
	RICHMOND, Va., May 13, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events: Jefferies Global Healthcare Conference – New York City, NY Joe Ciaffoni, Chief Executive Officer, and Ryan Preblick, Chief Financial......

12.05.25 - 07:03	Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies (GlobeNewswire EN)
	Ad Hoc Announcement Pursuant to Art. 53 LR...

01.05.25 - 16:30	New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy (PR Newswire)
	SUBLOCADE use during pregnancy showed no increased risk of birth defects, miscarriage, or maternal complications compared to general population rates RICHMOND, Va., May 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced the publication of a study "Monthly......

25.04.25 - 18:48	Indivior Non-GAAP EPS of $0.41 beats by $0.17, revenue of $266M beats by $23.7M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.25 - 23:00	Indivior (INDV) Q1 2025 Earnings Call (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.25 - 16:51	Indivior signals 2025 SUBLOCADE net revenue guidance of $725M-$765M amid expanded investments (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.25 - 14:30	Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates (Zacks)
	Indivior (INDV) delivered earnings and revenue surprises of 86.36% and 11.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

24.04.25 - 08:03	Indivior Announces Q1 2025 Financial Results (PR Newswire)
	SLOUGH, United Kingdom and RICHMOND, Va., April 24, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending March 31, 2025. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Im Winter beim Ofen, im Sommer im Feld. - Bauernregel - Bauernweisheit

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram